Korea Centers for Disease Control and Prevention, Cheongju, Korea
Copyright ©2020, Korea Centers for Disease Control and Prevention
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
COVID-19 National Emergency Response Center, Epidemiology and Case Management Team
Korea Centers for Disease Control and Prevention (KCDC):
Eun Kyeong Jeong
Center for Disease Prevention, KCDC: Ok Park, Young Joon Park, Shin Young Park, Young-Man Kim, Jieun Kim, Joongho Jo, Jungwoo Kim, Taeyoung Kim, Sanghui Kweon, Yeonhee Woo, Minwoo Yum, Eunyoung Kim
Center for Public Health Emergency Preparedness and Response, KCDC: Jin Gwack, Jin Lee, Eunmi Park, Seong Sun Kim, Junghee Hyun, Boyeong Ryu, Yoon Suk Jang, Hwami Kim, Yeowon Jin, Hyeyoung Lee, Sangeun Lee, Seung Hwan Shin, Seung Woo Choi, Daehyeon Ko, Seonju Yi, Hee Kyoung Kim
Center for Infectious Disease Control, KCDC: Dongwook Kim, Byoung-Hak Jeon, Miyoung Kim, Si won Choi
Center for Genome Science, KCDC: Jung Hyun Lee, Jae Kyung Park
Bureau of Health Policy, Ministry of Health and Welfare:
Unna Kim
Department of Social and Preventive Medicine, Hallym University College of Medicine: Young June Choe
Variables | Confirmed cases | Deaths | CFP | |
---|---|---|---|---|
|
|
|
||
n | % | n | % | |
Sex | ||||
Female | 4,808 | (62.0) | 25 | (0.5) |
Male | 2,947 | (38.0) | 35 | (1.2) |
| ||||
Age group (y) | ||||
0–9 | 75 | (1.0) | - | - |
10–19 | 405 | (5.2) | - | - |
20–29 | 2,238 | (28.9) | - | - |
30–39 | 804 | (10.4) | 1 | (0.1) |
40–49 | 1,082 | (14.0) | 1 | (0.1) |
50–59 | 1,472 | (19.0) | 6 | (0.4) |
60–69 | 960 | (12.4) | 14 | (1.5) |
70–79 | 483 | (6.2) | 24 | (5.0) |
≥ 80 | 236 | (3.0) | 20 | (8.5) |
| ||||
Total | 7,755 | 66 | (0.9) |
Age group (y) | Daegu | Gyeongbuk | Others | ||||||
---|---|---|---|---|---|---|---|---|---|
|
|
|
|||||||
Deaths | Total cases | CFP | Deaths | Total cases | CFP | Deaths | Total cases | CFP | |
0–9 | - | 48 | - | - | 9 | - | - | 18 | - |
| |||||||||
10–19 | - | 314 | - | - | 43 | - | - | 48 | - |
| |||||||||
20–29 | - | 1,787 | - | - | 279 | - | - | 173 | - |
| |||||||||
30–39 | - | 590 | - | - | 76 | - | 1 | 137 | (0.7) |
| |||||||||
40–49 | - | 778 | - | 1 | 142 | (0.7) | - | 162 | - |
| |||||||||
50–59 | 1 | 1,061 | (0.1) | 4 | 260 | (1.5) | 1 | 150 | (0.7) |
| |||||||||
60–69 | 10 | 719 | (1.4) | 4 | 162 | (2.5) | - | 79 | - |
| |||||||||
70–79 | 21 | 373 | (5.6) | 3 | 69 | (4.3) | - | 42 | - |
| |||||||||
≥ 80 | 15 | 124 | (12.1) | 4 | 96 | (4.2) | 1 | 16 | (6.3) |
| |||||||||
Total | 47 | 5,794 | (0.8) | 16 | 1,136 | (1.4) | 3 | 825 | (0.4) |
Variables | n | (%) |
---|---|---|
Age (y), median (range) | 77 | (35–93) |
| ||
Sex | ||
Female | 29 | (43.9) |
Male | 37 | (56.1) |
| ||
Coexisting condition* | ||
Any | 61 | (96.8) |
Cerebrovascular disease | 5 | (7.9) |
Heart disease | 10 | (15.9) |
Pulmonary disease | 11 | (17.5) |
Kidney disease | 5 | (7.9) |
Diabetes | 23 | (36.5) |
Hypertension | 30 | (47.6) |
Cancer | 7 | (11.1) |
Neurodegenerative disorder | 16 | (25.4) |
Under investigation | 5 | (6.5) |
| ||
Region | ||
Daegu | 47 | (71.2) |
Gyeongbuk | 16 | (24.2) |
Others | 3 | (4.5) |
| ||
Death while in home | 5 | (7.6) |
Diagnosis after death | 11 | (16.7) |
Interval, days, median (range) | ||
Symptom → Death | 10 | (1–24) |
Symptom → Diagnosis | 4 | (0–20) |
Symptom → Hospitalization | 4.5 | (0–11) |
Hospitalization → Death | 5 | (0–16) |
Total | 66 |
Demographics and case fatality proportion of the first 7,755 laboratory-confirmed COVID-19 cases, as of March 12th 2020, Republic of Korea.
Variables | Confirmed cases | Deaths | CFP | |
---|---|---|---|---|
|
|
| ||
n | % | n | % | |
Sex | ||||
Female | 4,808 | (62.0) | 25 | (0.5) |
Male | 2,947 | (38.0) | 35 | (1.2) |
| ||||
Age group (y) | ||||
0–9 | 75 | (1.0) | - | - |
10–19 | 405 | (5.2) | - | - |
20–29 | 2,238 | (28.9) | - | - |
30–39 | 804 | (10.4) | 1 | (0.1) |
40–49 | 1,082 | (14.0) | 1 | (0.1) |
50–59 | 1,472 | (19.0) | 6 | (0.4) |
60–69 | 960 | (12.4) | 14 | (1.5) |
70–79 | 483 | (6.2) | 24 | (5.0) |
≥ 80 | 236 | (3.0) | 20 | (8.5) |
| ||||
Total | 7,755 | 66 | (0.9) |
CFP = case fatality proportion.
Number of deaths and case fatality proportion for laboratory-confirmed COVID-19 cases by geographic region, as of March 12th 2020, Republic of Korea.
Age group (y) | Daegu | Gyeongbuk | Others | ||||||
---|---|---|---|---|---|---|---|---|---|
|
|
| |||||||
Deaths | Total cases | CFP | Deaths | Total cases | CFP | Deaths | Total cases | CFP | |
0–9 | - | 48 | - | - | 9 | - | - | 18 | - |
| |||||||||
10–19 | - | 314 | - | - | 43 | - | - | 48 | - |
| |||||||||
20–29 | - | 1,787 | - | - | 279 | - | - | 173 | - |
| |||||||||
30–39 | - | 590 | - | - | 76 | - | 1 | 137 | (0.7) |
| |||||||||
40–49 | - | 778 | - | 1 | 142 | (0.7) | - | 162 | - |
| |||||||||
50–59 | 1 | 1,061 | (0.1) | 4 | 260 | (1.5) | 1 | 150 | (0.7) |
| |||||||||
60–69 | 10 | 719 | (1.4) | 4 | 162 | (2.5) | - | 79 | - |
| |||||||||
70–79 | 21 | 373 | (5.6) | 3 | 69 | (4.3) | - | 42 | - |
| |||||||||
≥ 80 | 15 | 124 | (12.1) | 4 | 96 | (4.2) | 1 | 16 | (6.3) |
| |||||||||
Total | 47 | 5,794 | (0.8) | 16 | 1,136 | (1.4) | 3 | 825 | (0.4) |
CFP = case fatality proportion.
Fatal cases (n = 66) of laboratory-confirmed COVID -19 cases, as of March 12th 2020, Republic of Korea.
Variables | n | (%) |
---|---|---|
Age (y), median (range) | 77 | (35–93) |
| ||
Sex | ||
Female | 29 | (43.9) |
Male | 37 | (56.1) |
| ||
Coexisting condition* | ||
Any | 61 | (96.8) |
Cerebrovascular disease | 5 | (7.9) |
Heart disease | 10 | (15.9) |
Pulmonary disease | 11 | (17.5) |
Kidney disease | 5 | (7.9) |
Diabetes | 23 | (36.5) |
Hypertension | 30 | (47.6) |
Cancer | 7 | (11.1) |
Neurodegenerative disorder | 16 | (25.4) |
Under investigation | 5 | (6.5) |
| ||
Region | ||
Daegu | 47 | (71.2) |
Gyeongbuk | 16 | (24.2) |
Others | 3 | (4.5) |
| ||
Death while in home | 5 | (7.6) |
Diagnosis after death | 11 | (16.7) |
Interval, days, median (range) | ||
Symptom → Death | 10 | (1–24) |
Symptom → Diagnosis | 4 | (0–20) |
Symptom → Hospitalization | 4.5 | (0–11) |
Hospitalization → Death | 5 | (0–16) |
Total | 66 |
*A single case may have multiple comorbidities (investigation files required).
CFP = case fatality proportion.
CFP = case fatality proportion.
A single case may have multiple comorbidities (investigation files required).